Company Filing History:
Years Active: 2008
Title: Jeffrey Stephen Boyle: Innovator in Immune Response Technologies
Introduction
Jeffrey Stephen Boyle is a notable inventor based in Heidelberg, Australia. He has made significant contributions to the field of immunology, particularly in enhancing immune responses through innovative DNA molecules. With a total of 2 patents, Boyle's work is paving the way for advancements in immunogen targeting.
Latest Patents
Boyle's latest patents focus on methods for enhancing the immune response to immunogens. The first patent, titled "Immune response targeting molecules," provides methods and compositions for improving immune responses. This invention includes a DNA molecule designed to raise an immune response to an antigen, featuring a first sequence encoding a targeting molecule, a second sequence encoding the antigen or an epitope, and an optional third sequence for promoting dimerization or multimerization of the encoded product. The second patent, "Enhancement of immune response using targeting molecules," shares similar methodologies and compositions aimed at boosting immune responses through innovative DNA constructs.
Career Highlights
Jeffrey Boyle is currently associated with CSL Limited, a leading global biotechnology company. His work at CSL Limited has allowed him to focus on groundbreaking research in immunology, contributing to the development of novel therapeutic strategies.
Collaborations
Boyle has collaborated with talented individuals such as Jamie Louise Brady and Andrew Mark Lew. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful discoveries in the field.
Conclusion
Jeffrey Stephen Boyle's contributions to immunology through his patents and work at CSL Limited highlight his role as a key innovator in the field. His research continues to influence the development of new methods for enhancing immune responses, showcasing the importance of innovation in healthcare.